PathAI
AI pathology platform that analyzes tissue images and biomarkers to support drug development and clinical diagnostics in oncology.
About
PathAI provides AI-powered digital pathology tools for biopharma companies and anatomic pathology labs. Its core product, the AISight platform, is a cloud-native workflow solution that manages whole-slide imaging, case routing, and AI-driven analysis in a single environment. Disease-specific algorithms cover conditions such as MASH and ulcerative colitis, while biomarker quantification tools handle markers including PD-L1, HER2, ER, PR, and Ki67. Biopharma teams use PathAI to accelerate translational research and clinical trials; labs use it to improve throughput and consistency. Pricing is enterprise-based and available on request.